<?xml version="1.0" encoding="UTF-8"?>
<ref id="B45-marinedrugs-17-00567">
 <label>45.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>O’Keefe</surname>
    <given-names>B.R.</given-names>
   </name>
   <name>
    <surname>Vojdani</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Buffa</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Shattock</surname>
    <given-names>R.J.</given-names>
   </name>
   <name>
    <surname>Montefiori</surname>
    <given-names>D.C.</given-names>
   </name>
   <name>
    <surname>Bakke</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Mirsalis</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>d’Andrea</surname>
    <given-names>A.L.</given-names>
   </name>
   <name>
    <surname>Hume</surname>
    <given-names>S.D.</given-names>
   </name>
   <name>
    <surname>Bratcher</surname>
    <given-names>B.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>2009</year>
  <volume>106</volume>
  <fpage>6099</fpage>
  <lpage>6104</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.0901506106</pub-id>
  <pub-id pub-id-type="pmid">19332801</pub-id>
 </element-citation>
</ref>
